Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese medicine prescription orally taken for curing leukocytopenia

A technology of leukopenia and traditional Chinese medicine, which can be used in medical formula, extracellular fluid disease, anti-tumor drugs, etc., and can solve the problem of white blood cell drop and other problems

Inactive Publication Date: 2010-02-10
李秀英 +2
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Western medical treatment with vitamin B4, batyl alcohol, leucogen and hormone drugs has a certain effect, but after the drug is stopped, the white blood cells tend to fall again

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0021] Example 1: A traditional Chinese medicine prescription for the treatment of leukopenia for oral administration, the active ingredient raw material is made into the following weights: Caulis Spatholobus 30 grams, Psoraleae 10 grams, Poria cocos 10 grams, Amomum 10 grams, Atractylodes macrocephala 15 grams gram, 10 grams of medlar, 10 grams of angelica, 20 grams of astragalus, and 15 grams of Codonopsis.

[0022] Usage: 1 dose per day, 3 times a day, 2 weeks as a course of treatment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a Chinese traditional medicine prescribtion which is internally used for curing aleukocytosis. The invention is characterized in that the active ingredients of the invention are prepared by the following raw materials by weight: 30g of leatherleaf milletia, 10g of malaytea scurfpea, 10g of tuckahoes, 10g of amomum fruits, 15g of astraolylis lancea formalyrata, 10g of medlar, 10g of angelica, 20g of astragalus root, and 15g of codonopsis pilosula. The invention can be taken one dose per day and three times per day, and two weeks are one period of treatment. The inventionfor curing aleukocytosis has the advantages of obvious effect, lasting drug effect, no adverse reaction and side effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine prescription for oral administration for treating leukopenia, which belongs to the field of traditional Chinese medicines. Background technique [0002] Leukopenia refers to the peripheral blood, the total number of white blood cells continued to be lower than 4.0 × 109 / L. Modern medicine thinks that it can be seen in the secondary, and some of the reasons are unknown. Granulocytopenia can be hereditary, familial, acquired, etc., among which acquired is the majority. Drugs, radiation, infection, toxins, etc. can all cause neutropenia, and drugs are the most common. Patients may be asymptomatic or have nonspecific symptoms such as fatigue, anorexia, decreased energy, and a predisposition to infection. Whether co-infected neutropenia decreased degree. The most common sites of infection are the lungs, urinary tract, and skin. [0003] Western medical treatment with vitamin B4, batyl alcohol, leu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9064A61P7/00A61P35/02
Inventor 李秀英许恒忠李金英徐传国
Owner 李秀英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products